論文 - 成田 拓磨
-
Subsequent systemic therapy initiation after first-line discontinuation in metastatic renal cell carcinoma: insights from a Japanese real-world cohort.
Sato H, Narita T, Sekine Y, Shinohara M, Kawashima Y, Mori K, Numakura K, Kodama H, Mikami J, Fujita N, Okamoto T, Yamamoto H, Narita S, Sato S, Habuchi T, Ohyama C, Hatakeyama S
ESMO real world data and digital oncology 13 100733 2026年09月
-
Real-world trends in anti-androgen prescribing and associated costs for prostate cancer in Japan: a nationwide analysis.
Omizo S, Narita T, Hamaya T, Togashi K, Ogawa I, Tazawa S, Ishimoto K, Sakao M, Mikami J, Fujita N, Okamoto T, Imai A, Yamamoto H, Ohyama C, Hatakeyama S
Japanese journal of clinical oncology 2026年07月
-
Association of EVITA with safety in advanced urothelial carcinoma: A multicenter real-world study.
Ishimoto K, Narita T, Sekine Y, Shinohara M, Fujita N, Kawashima Y, Narita S, Kobayashi S, Abe N, Kodama H, Okamoto T, Yamamoto H, Numakura K, Sato S, Habuchi T, Ohyama C, Hatakeyama S
Urologic oncology 44 ( 9 ) 165 - 172 2026年06月
-
Real-world Outcomes of Adjuvant Nivolumab in High-risk Bladder and Upper Tract Urothelial Carcinoma after Radical Surgery.
Tazawa S, Shinohara M, Kawashima Y, Sekine Y, Narita S, Kobayashi S, Abe N, Narita T, Fujita N, Mikami J, Okamoto T, Yamamoto H, Numakura K, Sato S, Habuchi T, Ohyama C, Hatakeyama S
European urology open science 88 90 - 98 2026年06月
-
Visualizing eligibility gaps between muscle-invasive bladder cancer trials and real-world patients.
Ichiyama T, Narita T, Sekine Y, Shinohara M, Kawashima Y, Kobayashi M, Numakura K, Mikami J, Fujita N, Okamoto T, Yamamoto H, Narita S, Sato S, Habuchi T, Ohyama C, Hatakeyama S
Japanese journal of clinical oncology 2026年05月
-
CT-based renal artery caliber change as a potential imaging marker of treatment response in renal cell carcinoma; an exploratory imaging study.
Asanuma H, Okamoto T, Yoshizawa T, Oishi T, Hamaya T, Kodama H, Narita T, Mikami J, Fujita N, Yoneyama T, Yamamoto H, Imai A, Ohyama C, Hatakeyama S
Cancer imaging : the official publication of the International Cancer Imaging Society 26 ( 1 ) 2026年03月
-
Overactive Bladder Symptoms as a Predictor of Longitudinal Decline in Grip Strength in Community-Dwelling Men: A 4-Year Longitudinal Study.
Sato H, Okamoto T, Hamaya T, Kodama H, Narita T, Mikami J, Fujita N, Yamamoto H, Imai A, Murashita K, Nakaji S, Hatakeyama S
Lower urinary tract symptoms 18 ( 2 ) e70056 2026年03月
-
Immediate Postoperative cfDNA Elevation Predicts Pain After Robot-Assisted Radical Prostatectomy.
Ishii N, Yoneyama T, Minakawa S, Konishi S, Kodama H, Narita T, Mikami J, Fujita N, Okamoto T, Yamamoto H, Imai A, Ohyama C, Hatakeyama S
International journal of urology : official journal of the Japanese Urological Association 33 ( 1 ) e70297 2026年01月
-
Integrated Assessment of Percentage α2,3-Linked Sialylated Prostate-specific Antigen and the Prostate Health Index with Magnetic Resonance Imaging for Detection of Clinically Significant Prostate Cancer.
Oishi T, Yoneyama T, Miura Y, Hamaya T, Kodama H, Narita T, Mikami J, Fujita N, Okamoto T, Yamamoto H, Imai A, Ohyama C, Hatakeyama S
European urology open science 83 158 - 165 2026年01月
-
TMEM2 is a bona fide hyaluronidase possessing intrinsic catalytic activity.
Narita T, Tobisawa Y, Bobkov A, Jackson M, Ohyama C, Irie F, Yamaguchi Y
The Journal of biological chemistry 299 ( 9 ) 105120 2023年09月
-
Trends of incidence and age in adults with testicular germ cell tumors: a two-decade multicenter retrospective study.
Ozaki Y, Narita T, Hatakeyama S, Tanaka T, Togashi K, Hamaya T, Ozaki K, Ishi N, Oishi T, Tokui N, Mikami J, Okamoto T, Yamamoto H, Yoneyama T, Hashimoto Y, Ohyama C
Translational andrology and urology 12 ( 2 ) 161 - 167 2023年02月
-
Humoral response after SARS-CoV-2 mRNA vaccination in patients with prostate cancer using steroids.
Ishii N, Hatakeyama S, Yoneyama T, Tanaka R, Narita T, Fujita N, Okamoto T, Yamamoto H, Yoneyama T, Hashimoto Y, Ohyama C
Urologic oncology 40 ( 10 ) 451.e1 - 451.e8 2022年10月
-
Single immediate instillation of chemotherapy is associated with decreased recurrence and progression in patients with high-risk non-muscle-invasive bladder cancer who receive adjuvant induction bacillus Calmette-Guérin therapy.
Fujita N, Hatakeyama S, Momota M, Narita T, Tobisawa Y, Yoneyama T, Yamamoto H, Ito H, Yoneyama T, Hashimoto Y, Yoshikawa K, Ohyama C
International journal of urology : official journal of the Japanese Urological Association 29 ( 8 ) 867 - 875 2022年08月
-
Effect of active anticancer therapy on serologic response to SARS-CoV-2 BNT162b2 vaccine in patients with urothelial and renal cell carcinoma.
Togashi K, Hatakeyama S, Yoneyama T, Hamaya T, Narita T, Fujita N, Iwamura H, Okamoto T, Yamamoto H, Yoneyama T, Hashimoto Y, Ohyama C
International journal of urology : official journal of the Japanese Urological Association 29 ( 7 ) 733 - 739 2022年07月
-
Machine learning diagnosis by immunoglobulin N-glycan signatures for precision diagnosis of urological diseases.
Iwamura H, Mizuno K, Akamatsu S, Hatakeyama S, Tobisawa Y, Narita S, Narita T, Yamashita S, Kawamura S, Sakurai T, Fujita N, Kodama H, Noro D, Kakizaki I, Nakaji S, Itoh K, Tsuchiya N, Ito A, Habuchi T, Ohyama C, Yoneyama T
Cancer science 113 ( 7 ) 2434 - 2445 2022年07月
-
Significance of pelvic lymph node dissection during radical prostatectomy in high-risk prostate cancer patients receiving neoadjuvant chemohormonal therapy.
Iwamura H, Hatakeyama S, Narita T, Ozaki Y, Konishi S, Horiguchi H, Kodama H, Kojima Y, Fujita N, Okamoto T, Tobisawa Y, Yoneyama T, Yamamoto H, Yoneyama T, Hashimoto Y, Ohyama C
Scientific reports 12 ( 1 ) 9675 2022年06月
-
Management of bladder cancer in older patients.
Hatakeyama S, Narita S, Okita K, Narita T, Iwamura H, Fujita N, Inokuchi J, Matsui Y, Kitamura H, Ohyama C
Japanese journal of clinical oncology 52 ( 3 ) 203 - 213 2022年03月
-
Editorial Comment to Comparative oncological outcomes after radical prostatectomy or external beam radiation therapy plus androgen deprivation therapy in men with clinical T3b prostate cancer.
Narita T, Hatakeyama S, Ohyama C
International journal of urology : official journal of the Japanese Urological Association 2022年03月
-
Prognostic impact of proton pump inhibitors for immunotherapy in advanced urothelial carcinoma.
Okuyama Y, Hatakeyama S, Numakura K, Narita T, Tanaka T, Miura Y, Sasaki D, Noro D, Tokui N, Okamoto T, Yamamoto H, Narita S, Yoneyama T, Hashimoto Y, Habuchi T, Ohyama C
BJUI compass 3 ( 2 ) 154 - 161 2022年03月
-
Characteristics of α2,3-sialyl N-glycosylated PSA as a biomarker for clinically significant prostate cancer in men with elevated PSA level.
Yoneyama T, Yamamoto H, Sutoh Yoneyama M, Tobisawa Y, Hatakeyama S, Narita T, Kodama H, Momota M, Ito H, Narita S, Tsushima F, Mitsuzuka K, Yoneyama T, Hashimoto Y, Duivenvoorden W, Pinthus JH, Kakeda S, Ito A, Tsuchiya N, Habuchi T, Ohyama C
The Prostate 81 ( 16 ) 1411 - 1427 2021年12月